The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: viramune     Quarter: 2016Q3

Total Records: 153     Number of Pages: 8

DRUGNAME PT EventCount
VIRAMUNE Cardiac failure congestive 5
VIRAMUNE Embolism venous 5
VIRAMUNE Hypertension 5
VIRAMUNE Live birth 5
VIRAMUNE Maternal exposure during pregnancy 5
VIRAMUNE Speech disorder 5
VIRAMUNE Abnormal behaviour 4
VIRAMUNE Aspartate aminotransferase increased 4
VIRAMUNE Blood lactate dehydrogenase increased 4
VIRAMUNE Cardiovascular disorder 4
VIRAMUNE Cerebrovascular accident 4
VIRAMUNE Depression 4
VIRAMUNE Electroencephalogram abnormal 4
VIRAMUNE Foetal distress syndrome 4
VIRAMUNE Gastrointestinal disorder 4
VIRAMUNE Gastrointestinal haemorrhage 4
VIRAMUNE Haematochezia 4
VIRAMUNE Hepatic enzyme increased 4
VIRAMUNE Hepatomegaly 4
VIRAMUNE Lactic acidosis 4

Total Records: 153     Number of Pages: 8